Showing results (21-30 of 152) with videos related to
Sort By:
Pageof 16
Clinical Hemorheology and Microcirculation|November 21, 2019
The role of arginase in the microcirculation in cardiovascular diseaseBernhard Wernly, John Pernow, Malte Kelm, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 16, 2023
Erythrocyte-Derived microRNAs: Emerging Players in Cardiovascular and Metabolic DiseaseEftychia Kontidou, Aida Collado, John Pernow, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|August 26, 2003
L-arginine protects from ischemia-reperfusion-induced endothelial dysfunction in humans in vivoJohn Pernow, Felix Bohm, Emma Beltran, et al.Regulatory Peptides|December 8, 2004
Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanismThomas Nyström, Adrian T Gonon, Ake Sjöholm, et al.Clinical Science (London, England : 1979)|December 22, 2004
The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humansFelix Böhm, Magnus Settergren, Adrian T Gonon, et al.British Journal of Pharmacology|February 3, 2005
Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heartAdrian T Gonon, Alexander Bulhak, Anders Bröijersén, et al.Cardiovascular Research|June 14, 2002
Pharmacological possibilities for protection against myocardial reperfusion injuryQing-Dong Wang, John Pernow, Per-Ove Sjöquist, et al.Burns : Journal of the International Society for Burn Injuries|May 1, 2007
Small skin burn injury reduces cardiac tolerance to ischemia via a tumor necrosis factor alpha-dependent pathwayFausto Labruto, John Pernow, Jangning Yang, et al.Canadian Journal of Physiology and Pharmacology|November 18, 2008
Intracoronary endothelin receptor blockade improves endothelial function in patients with coronary artery diseaseFelix Böhm, Jens Jensen, Bertil Svane, et al.Ebiomedicine|January 25, 2022
Mendelian randomization study on the causal effects of tumor necrosis factor inhibition on coronary artery disease and ischemic stroke among the general populationXiaoying Kang, Tong Jiao, Haiyang Wang, et al.Pageof 16